BeStock  
Stocks › Biotechnology › PTCT

PTC Therapeutics PTCT

US equityMarket cap rank #2094Biotechnology
$56.42 −$1.91 (-3.27%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $56.99 +1.01%
Open$58.78
Prev close$58.33
Day range$56.18 – $58.96
Volume952.6K
Market cap$4.71B
P/E (TTM)–
Dividend yield–

PTCT Stock News

Headlines matching PTC Therapeutics or the PTCT ticker, most recent first.

  • Cantor Fitzgerald Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Raises Target Price to $137 PositiveMarket news · 22 Sep 2026 · Direct mention
  • Wells Fargo Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $109Market news · 2 Sep 2026 · Direct mention
  • Barclays Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $120Market news · 4 Aug 2026 · Direct mention
  • TD Cowen Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $90Market news · 31 Aug 2026 · Direct mention
  • PTC Therapeutics, Inc.: To Assume Certain Specified Liabilities of Sangamo PTCTDow Jones · 29 Aug 2026 · Direct mention
  • PTC Therapeutics, Inc.: Upfront Payment of $111 Million, Plus Up to an Additional $100 Million in Contingent Milestone Payments PTCTDow Jones · 29 Aug 2026 · Direct mention
  • Barclays Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Raises Target Price to $122 PositiveMarket news · 14 Aug 2026 · Direct mention
  • Cantor Fitzgerald Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $130Market news · 13 Aug 2026 · Direct mention
  • Wells Fargo Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Raises Target Price to $109 PositiveMarket news · 13 Aug 2026 · Direct mention
  • BofA Securities Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $96Market news · 13 Aug 2026 · Direct mention
  • Goldman Sachs Maintains PTC Therapeutics(PTCT.US) With Sell Rating, Raises Target Price to $70 PositiveMarket news · 31 Jul 2026 · Direct mention
  • A Quick Look at Today's Ratings for PTC Therapeutics(PTCT.US), With a Forecast Between $90 to $106Market news · 31 Jul 2026 · Direct mention
  • Wells Fargo Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $106Market news · 31 Jul 2026 · Direct mention
  • Morgan Stanley Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Raises Target Price to $104 PositiveMarket news · 31 Jul 2026 · Direct mention
  • RBC Capital Maintains PTC Therapeutics(PTCT.US) With Hold Rating, Raises Target Price to $85 PositiveMarket news · 27 Jul 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on PTCT.

Sign in to join the discussion.

Scroll to Top